Cargando…
Effect of bupivacaine lozenges on oral mucositis pain: a randomized controlled multicenter phase II study
INTRODUCTION: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated administration of a bupivacaine lozenge (25 mg) as pain management for oral mucositis pain in head and neck cancer patients as add-on to standard systemic pain management. OBJ...
Autores principales: | Mogensen, Stine, Treldal, Charlotte, Kristensen, Claus A., Bentzen, Jens, Lawson-Smith, Louise, Petersen, Janne, Andersen, Ove |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777682/ https://www.ncbi.nlm.nih.gov/pubmed/29392234 http://dx.doi.org/10.1097/PR9.0000000000000619 |
Ejemplares similares
-
A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study
por: Mogensen, Stine, et al.
Publicado: (2016) -
Bupivacaine Lozenge Compared with Lidocaine Spray as Topical Pharyngeal Anesthetic before Unsedated Upper Gastrointestinal Endoscopy: A Randomized, Controlled Trial
por: Salale, Nesrin, et al.
Publicado: (2014) -
New lidocaine lozenge as topical anesthesia compared to lidocaine viscous oral solution before upper gastrointestinal endoscopy
por: Mogensen, Stine, et al.
Publicado: (2012) -
Natural history of pain associated with melanoma surgery
por: Slagelse, Charlotte, et al.
Publicado: (2018) -
Mice with cancer-induced bone pain show a marked decline in day/night activity
por: Majuta, Lisa A., et al.
Publicado: (2017)